Related Experiment Video
Updated: Oct 7, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Atypical presentations and course of JC virus infection
Sophie Chatterton1,2, Liam Dwyer1,2, Claire Thomson3
1St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
Abstract:
There is increasing evidence that the spectrum of human polyomavirus 2 (JCV) CNS disease includes novel syndromes other than progressive multifocal leukoencephalopathy (PML), the appreciation of which is increasingly important in the context of MS therapies and immunodeficiency states. Our objective is to describe unusual presentations of JCV infection to heighten clinician awareness. We describe three case reports of various PML presentations. Firstly a 56-year-old HIV positive male with decades of viral suppression and normal immune function presented with 1 month of non-specific headache that spontaneously resolved despite an MRI showing a new area of PML and CSF being JC DNA + . He had had two similar episodes in 2013 and 2014 with MRI scans consistent with PML, CSF, JCV, and PCR positivity once and brain biopsy-positive twice. Another 61-year-old male presented with subacute binocular vision loss and was found to have newly diagnosed HIV and JCV DNA detected in CSF. MRI brain only demonstrated symmetrical chiasmo-hypothalamic enhancement. There has been some improvement with combination antiretroviral therapy and corticosteroids for immune reconstitution inflammatory syndrome (IRIS). Thirdly, a 65-year-old male presented with subacute progressive confusion and behavioural disturbance, one year post-bilateral lung transplantation. MRI brain demonstrated no evidence of PML but CSF on three occasions demonstrated a progressively increasing JCV DNA load. Despite reduction in his immunosuppression, the patient developed profound encephalopathy without localising features leading to death two months later. These cases emphasise the atypical presentations of JCV: chronic relapsing, unusual symmetrical visual pathway disease, and non-localising encephalopathy without MRI evidence of PML.
Insights
Human polyomavirus 2 (JCV) infections can present with unusual neurological syndromes beyond progressive multifocal leukoencephalopathy (PML). Recognizing these varied JCV presentations is crucial for diagnosing and managing patients, especially those with immunodeficiency.
Area of Science:
- Neurovirology
- Immunocompromised Host Infections
- Central Nervous System (CNS) Diseases
Background:
- Human polyomavirus 2 (JCV) is increasingly recognized to cause a spectrum of central nervous system (CNS) diseases beyond the typical progressive multifocal leukoencephalopathy (PML).
- Understanding these diverse JCV manifestations is critical, particularly in patients with immunodeficiency or those undergoing immunosuppressive therapies like multiple sclerosis (MS) treatments.
- This study aims to increase clinician awareness of unusual presentations of JCV infection.
Observation:
- Case 1: An HIV-positive male with suppressed viral load presented with headache and MRI findings of PML, despite a history of similar resolved episodes.
- Case 2: A 61-year-old male with newly diagnosed HIV experienced subacute binocular vision loss, with CSF positive for JCV DNA and MRI showing chiasmo-hypothalamic enhancement.
- Case 3: A lung transplant recipient developed progressive confusion and behavioral changes, with increasing JCV DNA in CSF but no MRI evidence of PML, ultimately leading to fatal encephalopathy.
Findings:
- JCV infection can manifest atypically, including chronic relapsing courses and unusual patterns of CNS involvement.
- Symmetrical visual pathway disease and non-localizing encephalopathy without MRI evidence of PML represent less common but significant presentations of JCV infection.
- These cases highlight the diagnostic challenges posed by JCV in immunocompromised individuals.
Implications:
- Heightened clinical suspicion for JCV is warranted in patients with unexplained neurological symptoms, especially those with altered immune status.
- Early recognition of diverse JCV presentations can guide appropriate diagnostic workup, including CSF analysis for JCV DNA.
- Management strategies may involve adjusting immunosuppression and considering specific antiviral or immunomodulatory therapies.
More Related Videos
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
12:20Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Stages of Infection
Retroviruses
Retrovirus Life Cycles
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies